Introduction {#s0005}
============

Analysis of mutations affecting genes that are essential for survival in model organisms, such as the nematode *Caenorhabditis elegans*, have been instrumental in developing our understanding of fundamental biological processes, for example cell division and morphology among others ([@bb0005]). Many of these processes have a direct relevance to the understanding of human diseases such as metabolic disorders and obesity ([@bb0010]). The generation of mutations in essential genes and their correlation with a specific genetic locus is, therefore, the first step in understanding the nature of a gene\'s function in promoting survival. To more easily identify genes that are essential for survival in the model organism *C. elegans*, we created a physical deficiency map that encompasses a portion of Chromosome IV, allowing for the correlation of genetically defined mutations with physically defined candidate gene lists. In this study, we describe the use of this physical deficiency map to identify the essential gene (*let-65)*, previously isolated from ethyl methanesulfonate (EMS) genetic screens ([@bb0015], [@bb0020], [@bb0025], [@bb0035], [@bb0030]). From this analysis we determined that mutations in *let-65* correspond to the methionyl tRNA synthetase gene, *mars-1*.

Organisms utilize four key components to translate genetic information into proteins: ribosomes, messenger RNAs (mRNA), transfer RNAs (tRNA), and aminoacyl-tRNA synthetases (ARS), reviewed in [@bb0040]. Ribosomes are two-subunit organelles that direct synthesis of proteins by translating nucleic acid triplets, carried by mRNAs, into amino acids ([@bb0045]). mRNAs, which are generated by DNA transcription, act as translation templates, whereas tRNAs act as interfaces between mRNA strands and the amino acids added to a polypeptide chain by transferring the required amino acids to the growing chain ([@bb0045]).

The ARS family of proteins encompasses more than 20 multi-domain enzymes. Each of these proteins specifically recognizes one amino acid and its corresponding subset of cognate tRNA molecules to catalyze the aminoacylation of the former to the latter in a two-step reaction. In the first step a specific amino acid is activated by ATP to produce aminoacyl adenylate; in the second step the amino acid is transferred onto the 3′-end of the tRNA ([@bb0050]). ARS are categorized into two classes (I and II) based on their distinct core domains ([@bb0055]). The catalytic domain of Class I synthetases exhibit a typical Rossman fold, which has a three-layer topology (α/β/α) with an inner core of five parallel beta strands. However, Class II synthetases generally consist of only β strands ([@bb0060]). Class I and II synthetases recognize different faces of tRNA molecules ([@bb0060]). The tRNA CCA terminus (containing the amino acid attachment site) adopts different conformations in tRNA-synthetase complexes for each class. The CCA termini of Class I enzymes have hairpin conformations, whereas, class II enzymes have the same helical confirmations observed in free tRNAs ([@bb0060]). An intriguing enzyme that belongs to this family is the Class I synthetase, methionyl tRNA synthetase (MetRS), which recognizes both the initiator tRNA as well as the methionine carrying tRNA that functions in the elongation of peptide chains ([@bb0065]).

In this study, we use oligonucleotide array Comparative Genomic Hybridization (aCGH) to define a physical deficiency map of a region of Chromosome IV (LGIV) in the nematode *C. elegans*. We then use this map to assign precisely defined lists of candidate genes to previously generated and genetically mapped mutations, which confer a lethal phenotype upon the organism. Using this approach, we demonstrate that the lethality associated with alleles of *let-65* is fully rescued by a transgenic array that spans the *mars-1* genomic region.

Materials and methods {#s0010}
=====================

Growth and handling of *C. elegans* {#s0015}
-----------------------------------

Nematode strains were cultured as previously described ([@bb0070]). Strains used in this study: N2 Bristol (BC00049), *dpy-5*(*e907*) (CB00907), *let-65*(*s254*); *nT1*(*IV*) (BC00962), *let-65*(*s694*); *nT1*(*IV*) (BC1121), *let-65*(*s1154*); *nT1*(*IV*) (BC2028), *let-65*(*s1222*); *nT1*(*IV*) (BC2116), *let-65*(*s1083*); *nT1*(*IV*) (BC1909), *let-65*(*s1084*); *nT1*(*IV*) (BC1910), *let-65*(*s1730*); *nT1*(*IV*) (BC3258), *let-65*(*s1777*); *nT1*(*IV*) (BC3305), *let-65*(*s1083*), *unc-22*(*s7*)(*IV*) \[*WRM0615dH10* + *myo-2*::*GFP* + *pCeh361*\] (BC8656), *let-65*(*s1222*), *unc-22*(*s7*) (*IV*) \[*WRM0615dH10* + *myo-2*::*GFP* + *pCeh361*\] (BC8696).

Oligonucleotide array comparative genomic hybridization (aCGH) data analysis {#s0020}
----------------------------------------------------------------------------

aCGH experiments and analysis were performed as previously described ([@bb0075]).

DNA sequence analysis {#s0025}
---------------------

Genomic DNA was extracted from *let-65* homozygous animals for eight alleles (*s1730*, *s1083*, *s694*, *s1084*, *s254*, *s1154*, *s1777* and *s1222*). PCR fragments spanning the *mars-1* ORF were amplified from genomic DNA templates with primers designed using Primer 3 ([@bb0080]) (primer sequences available upon request). The amplified templates were subsequently sequenced (Macrogen, Korea) with appropriate sequencing primers ([Supplementary Table 1](#ec0005){ref-type="supplementary-material"}).

Transgenic rescue {#s0030}
-----------------

The fosmid *WRM0615dH10*, which spans the *mars-1* genomic region (11,631,182 to 11,665,626 bp on LGIV), was injected into the syncytial gonads of *dpy-5* (*e907*) animals at a final concentration of 3 ng/μl, along with the pharyngeal targeted green fluorescent protein (GFP) reporter *myo-2*::*GFP* at 10 ng/μl and the plasmid *pCeh361*,which contains wild-type *dpy-5* that rescues the *dpy-5* phenotype, at 100 ng/μl ([@bb0085]). Injected worms were plated (five P~0~s per plate) and phenotypically wild-type animals from the F~1~s generation that expressed the pharyngeal GFP reporter were individually isolated and propagated. GFP positive wild-type F~2~ animals transmitting the transgenic array were selected and a PCR specific to the fosmid backbone performed to confirm the presence of the fosmid ([Supplementary Table 1](#ec0005){ref-type="supplementary-material"}). A single, stably transmitting, animal was selected to create transgenic lines. To conduct transgenic rescue experiments individual hermaphrodites carrying *WRM0615dH10* + *myo-2*::GFP + *pCeh361* were crossed to +/+ N2 males to obtain *dpy-5* (*e907*)/+\[*WRM0615dH10* + *myo-2*::GFP + *pCeh361*\] males. These GFP-expressing males were then crossed to *let-65* (*s1222*); *unc-22* (*s7*) *and let-65* (*s1803*); *unc-22* (*s7*) heterozygously maintained hermaphrodites. F~1~ progeny were screened for the presence of males to ensure the cross was successful and F~1~ wild-type hermaphrodites plated individually. F~2~ animals were individually plated and screened for unconditional twitchers, which is indicative of viable homozygous animals of the genotype *let-65* (*s1083* or *s1222*) *unc-22* (*s7*)/*let-65* (*s1083* or *s1222*) *unc-22* (*s7*)(*IV*)\[*WRM0615dH10* + *myo2*::GFP + *pCeh361*\]*.* Unconditional twitchers were individually plated and incubated at 20 °C to assess rescue.

Microscopy {#s0035}
----------

Screening of transgenic animals was performed using a Zeiss Axioscope (Quorum Technologies) set with a QImaging Camera and appropriate filter sets were used for GFP expression analysis. Animals were immobilized with 100 mM sodium azide (in water) immediately prior to imaging.

Bioinformatics studies {#s0040}
----------------------

All reference DNA sequences were derived from WormBase release WS208. Analysis of sequence data and image processing were performed using BioEdit (<http://www.mbio.ncsu.edu/BioEdit/BioEdit.html>), WolFPSORT ([@bb0090]) (<http://wolfpsort.org/>), and BLASTP.

Results {#s0045}
=======

aCGH mapped deficiencies physically define seven zones in the *unc-22* region of LGIV {#s0050}
-------------------------------------------------------------------------------------

In an effort to characterize genes that are essential for survival in *C. elegans* we previously generated and mapped mutations that confer a lethal phenotype in the *unc-22* region of the *C. elegans* genome ([@bb0030]). The *unc-22* region (from *unc-43* to *unc-31*) represents approximately two map units (mu) on chromosome IV, which is spanned by 35 well-defined genetic deficiencies ([@bb0015], [@bb0020], [@bb0100], [@bb0025], [@bb0035], [@bb0030], [@bb0095]). Previously, genetic analysis was used to identify and position 31 lethal gene loci within this genetic deficiency map ([@bb0020]). However, because the precise molecular extent of the deficiencies was not known the construction of definitive candidate gene lists that corresponded to each mutated loci was not possible.

To physically define the deficiency map in the *unc-22* region we analyzed four of the most informative deficiencies using array comparative genomic hybridization (aCGH). aCGH is a method used to compare the DNA ratio between individual samples from the same organism in order to determine copy number variations on a chromosomal or genome-wide scale ([@bb0105]). This method can be used to determine the precise physical extent of genetic deficiencies in *C. elegans* ([@bb0075]). In all four cases, array data was sufficient to position deficiency deletion breakpoints at a single-gene resolution to within approximately 6 kb ([Table 1](#t0005){ref-type="table"}). Deletion breakpoints fell either within single genes or between two genes. Using these data a seven-zone physical deficiency map was constructed spanning approximately 800 kb of the *unc-22* region ([Fig. 1](#f0005){ref-type="fig"}A and [Table 1](#t0005){ref-type="table"}). Furthermore, by incorporating previously generated genetic mapping data for the molecularly unidentified lethal loci known to map into the region, we were able to assign each locus to a precisely defined list of candidate genes. The largest number of lethal loci map into zone two of the deficiency map (nine genes). Zone six contains seven lethal loci, while zones four and seven contain six lethal loci each. Zones one and five contain three lethal loci each. Finally, a single lethal locus was positioned into zone three ([Fig. 1](#f0005){ref-type="fig"}A).

Sequence analysis of *let-65* {#s0055}
-----------------------------

*let-65* was the single lethal loci that mapped into zone three of the deficiency map ([Fig. 1](#f0005){ref-type="fig"}A). Based on the physical extent of zone three only four annotated genes, F58B3.4, F58B3.5, F58B3.6 and F58B3.7 were candidates for *let-65. let-65* is represented by nine alleles, all of which were isolated in EMS screens for larval lethality ([@bb0015], [@bb0020], [@bb0035], [@bb0030]). Since mutations in *let-65* confer a lethal phenotype we correlated available RNAi data in order to rank the candidate genes based upon the severity of the reported RNAi phenotype ([@bb0110], [@bb0115], [@bb0120], [@bb0125], [@bb0130]) ([Fig. 1](#f0005){ref-type="fig"}B). Using this approach we identified F58B3.5 and F58B3.4 as the two strongest candidate genes. To identify mutations in F58B3.5 and F58B3.4 their genomic regions were amplified by PCR from *let-65* (*s254*) homozygous animals and sequenced. A comparison of sequence data to the reference *C. elegans* genome (WormBase release WS208) revealed no mutations that were associated with F58B3.4. However, a point mutation was identified in the coding region of F58B3.5. This mutation resulted in a glutamic acid to lysine substitution (Glu364Lys) in a highly conserved amino acid ([Fig. 2](#f0010){ref-type="fig"} and [Table 2](#t0010){ref-type="table"}). To provide additional confirmation that mutation of F58B3.5 was associated with *let-65* we sequenced the F58B3.5 ORF in the remaining *let-65* alleles, detecting the presence of additional mutations in seven of the eight alleles tested. All mutations identified were G → C to A → T transitions, consistent with the known mutational spectrum for ethane methylsulfonate (EMS) mutagenesis ([Fig. 2](#f0010){ref-type="fig"}, [Table 2](#t0010){ref-type="table"}) ([@bb0135]). In every case, with the exception of *s1777 and s1222*, the identified mutations were substitutions in highly conserved amino acids in the predicted MetRS domain of F58B3.5 ([Figs. 1](#f0005){ref-type="fig"}C and [2](#f0010){ref-type="fig"}). The lesion *s1777* resulted in a 508 amino acid truncation, while *s1222* contained a mutation in the first base of the first intron. *s1222* potentially prevents splicing of the first intron, which would result in a premature truncation of the protein at amino acid 28 ([Fig. 1](#f0005){ref-type="fig"}C). Together these data demonstrate that *let-65* and F58B3.5 represent the same gene. F58B3.5 encodes a cytoplasmic Class I synthetase, methionyl tRNA synthetase (MetRS) that is evolutionary well conserved, with 58% identity and 71% similarity to its human homologue (BlastP alignment [@bb0140], [@bb0145]) ([Fig. 2](#f0010){ref-type="fig"}). We have renamed F58B3.5 *mars-1* ([M]{.ul}ethionyl [A]{.ul}mino-acyl t[R]{.ul}NA [S]{.ul}ynthetase-1).

Rescue of *let-65* with a fosmid containing *mars-1* {#s0060}
----------------------------------------------------

We have shown that mutations of *mars-1* are present in *let-65* animals. To provide further evidence that these mutations caused the lethality associated with *let-65*, we performed transgenic rescue experiments. The fosmid clone *WRM0615dH10* spans the entire *mars-1* genomic region, but excludes the F58B3.4 ORF ([Fig. 1](#f0005){ref-type="fig"}B). We found that transgenic animals carrying *WRM0615dH10* as an extra-chromosomal array successfully and specifically rescued the lethality associated with the two alleles of *let-65* tested (*s1083* and *s1222*). Furthermore these transgenic animals were superficially wild type in appearance except for the twitching phenotype due to the presence of the *unc-22* (*s7*) homozygous mutation, which was used as a visible phenotypic marker. Individual viable animals were isolated to start the strains BC8656 and BC8696 for alleles *s1083* and *s1222* respectively, and cultured over multiple generations to confirm continued rescue of the lethal phenotype. Together the sequence and rescue data confirm that mutation of *mars-1* gives rise to the lethal phenotype in *let-65* animals.

Mitochondrial methionyl tRNA synthetase candidate {#s0065}
-------------------------------------------------

MARS-1 has been predicted to encode the cytoplasmic form of MetRS ([@bb0150]). Computational analysis of the predicted MARS-1 protein (WormBase WS209) demonstrated that *mars-1* encodes a protein that localizes subcellularly in the cytoplasm. BLASTP analysis of Y105E8A.20 ([@bb0140]), a second gene predicted to encode methionyl tRNA synthetase in *C. elegans* (WormBase WS211), implies mitochondrial localization for the encoded protein.

Discussion {#s0070}
==========

In this study we used aCGH to define a physical deficiency map for a 2 Mb portion of LGIV in *C. elegans*. Using this deficiency map we correlated physical candidate gene lists with mutations in a number of previously identified essential genes ([@bb0160], [@bb0155], [@bb0165], [@bb0035], [@bb0030]). From our analysis we were able to determine that the genetically identified locus *let-65* corresponds to *mars-1*, which encodes the *C. elegans* homologue of MetRS. *let-65* is one of a number of lethal genes previously identified in EMS screens for essential genes on the right end of LGIV. These screens generated seven alleles for *let-65* six of which resulted in lethality (*s253*, *s1777*, *s1083*, *s1154*, *s1222* and *s1730*), and one additional allele causing sterility (*s694*). Previously it has been reported that inactivation of MARS-1 by RNAi leads to embryonic lethality ([@bb0110], [@bb0130]). Moreover, this loss of MARS-1 function can also lead to sterility ([@bb0170]). Furthermore, correlation of available phenotypic information for other ARS family members deleted by targeted mutations demonstrates a complete correlation of lethal and sterile phenotypes, highlighting the essential nature of this family of enzymes ([Table 3](#t0015){ref-type="table"}). Together these data indicate that *mars-1* is essential for processes that require large scale protein biosynthesis, such as embryogenesis ([@bb0170]).

In *C. elegans* cytoplasmic MetRS (MARS-1) is a 917 amino acid protein that has multiple predicted functional domains. The minimal core enzyme, as found in the bacteria *Aquifex aeolicus*, consists of a core catalytic domain (CAT), which is distinguished by a Rossmann fold that is a characteristic domain of Class I aminoacyl tRNA synthetase enzymes (catalyzes the aminoacylation reaction), and an anticodon-binding domain (ABD) (promotes tRNA--protein association) ([@bb0175]). Additional domains, found in eukaryotes, are appended in front of or after the core domain of the enzyme and are believed to increase the stability of tRNA--protein complexes ([@bb0150]). In humans, MARS carries a C-terminal domain that causes a slow release of aminoacyl-tRNA and provides the aminoacylation reaction with a limiting step ([@bb0150]). In *C. elegans*, the MARS-1 protein model contains a t-RNA binding domain (tRBD) of about 170 residues appended in *cis* at the C-terminus of the enzyme, which is homologous to the tRBD domain appended at the C-terminus of MetRS in *Oriza sativa* (rice) ([@bb0150]). However, in *C. elegans*, this domain is separated from the ABD domain by a putative protein-binding domain of approximately 150 residues ([@bb0150]). This domain is similar to the human P43 protein, which is a non-synthetase component of the aminoacyl tRNA synthetase complex required for the assembly of the protein within the complex ([@bb0170]). The predicted *C. elegans* MARS-1 catalytic core domain comprises amino acids 36 to 407 ([@bb0180]). In *let-65* six out of the eight mutations reside in this domain (*s1730*, *s1083*, *s694*, *s1084*, *s254* and *s1154*) suggesting that they disrupt the function of the catalytic core. The EMS induced mutation in *let-65*(*s1777*) creates a truncated protein that lacks the anticodon-binding domain (AA416 to AA545) ([@bb0180]) and the tRNA binding domain (AA755 to AA857) ([@bb0180]). *let-65*(*s1222*) contains a mutation in the first base of the first intron putatively preventing splicing of the first intron resulting in putative premature truncation at amino acid 28.

*mars-1* is highly conserved and encodes a protein with unique significance for translational control. Structures of MARS-1 from *Escherichia coli* ([@bb0185]) and *Thermus thermophiles* ([@bb0190]) have been reported. MARS-1 from *E. coli* has greater identity than *T. thermophiles* to the protein in *C. elegans*. Amino acids altered in four of the six *C. elegans* missense mutations are located in conserved regions in both *E. coli* and *T. thermophiles*: *let-65*(*s1083*): βC; *let-65*(*s694*): turn between β2 and β3 (zinc-binding domain); *let-65*(*s254*): turn between β7 and α6; *let-65*(*s1154*): turn between α7 and β8. *let-65*(*s1730*) is in turn between βA and αA and *let-65*(*s1084*) is in turn between β5 and β6. All identified *let-65* changes are located in *E. coli* at the Rossman-like fold.

*let-65*(*s1777*) contains a nonsense mutation wherein the tryptophan codon at amino acid 408 becomes an amber stop codon. *let-65*(*s1222*) has a mutation that putatively prevents splicing of the first intron resulting in premature truncation, the truncated protein lacks the majority of the synthetase including the catalytic domain, the two binding domains, the anticodon-binding domain, and the tRNA binding domain. *s1777* and *s1222* are, therefore, both putatively null alleles. The phenotypes (mid-larval arrest) ([@bb0015], [@bb0020]) of these two mutants are indistinguishable from six other *let-65* alleles. Based on this observation we predict that all six alleles are null for MARS-1 function, or reduce MARS-1 activity below a threshold required for survival. Moreover, the survival of nematodes, containing those alleles to mid-larva, suggests that for the early developmental stages, the mother supplies MARS-1 to eggs during oogenesis.

*let-65*(*s694*) and *let-65*(*s1083*) contain mutations that change glycine to glutamic acid at amino acids 186 and 126 respectively. These two amino acids are in sequence blocks that are conserved from human to yeast. *let-65*(*s1084*) contains a mutation that changes glycine to arginine at amino acid 275. Generally, a change from a small non-charged non-hydrophilic glycine to a large positively charged hydrophilic arginine could disrupt the structure of a protein enough to render it non-functional, which in the case of *let-65* would cause lethality. *let-65* (*s1730*) contains a mutation that changes alanine to valine at position 41. In humans, *Drosophila melanogaster* and *Saccharomyces cerevisiae*, a serine codon is located at the same position within a highly conserved sequence block. Because a change from a polar amino acid (serine) to a non-polar amino acid (valine) could disrupt the protein\'s structure more than replacing alanine with valine we analyzed the available sequences to confirm the *C. elegans* wild type reference sequence at position 41. After analyzing the same sequence stretch in the other *let-65* alleles we concluded definitively that an alanine is present at position 41. The mutation in *let-65*(*s254*) replaces a conserved acidic amino acid (glutamic acid) with a basic amino acid (lysine) at position 364. This position is within the catalytic domain of MARS-1. *let-65*(*s1154*) has a polar amino acid (proline) instead of the non-polar amino acid (leucine) at position 400 that is within the catalytic domain. Additionally, since alterations of proline in the flanking regions of active sites are known to change the activity of the protein (Proline bracket hypothesis) ([@bb0195]), this mutation may exhibit drastic effects on MARS-1 activity.

Typically, eukaryotic cells have two forms of ARS: cytoplasmic and mitochondrial ([@bb0200]). MARS-1 localizes to the cytoplasm ([@bb0150]). Therefore, we attempted to find the candidate gene coding for the mitochondrial form of the enzyme. The *C. elegans* genome contains a second ORF, Y105E8A.20 that is predicted to encode a methionyl tRNA synthetase (WormBase WS211). Y105E8A.20 is a 1221 bp gene that encodes a 406 amino acid protein. BlastP was used to search the Swiss-Prot database with MARS-1 amino acid sequences as queries ([@bb0140], [@bb0145]). In the BlastP searches *S. cerevisiae* was used as the canonical genome to identify protein localizations in *C. elegans*. *S. cerevisiae* was used because it\'s one of the simplest in regard to identifying open reading frames (ORFs), and it is the most highly characterized eukaryotic genome ([@bb0205]). BlastP localization, based on *S. cerevisiae* matches, predicted mitochondrial localization for the protein encoded by Y105E8A.20.

The *C. elegans* million mutations project (MMP) comprises a library of 2007 mutagenized and homozygous *C. elegans* strains that were sequenced to identify the resulting mutations. The aim of this project was to generate mutant alleles in each gene in the *C. elegans* genome. However, a limitation of this approach is that severely detrimental mutations in genes required for viability would be selected against since these strains must be viable and fertile. Of the 14 MMP mutations that are recorded for *mars-1*, all are missense mutations with the single exception of a mutation that is predicted to affect splicing of an intron in the C-terminus of the protein. This intron is not conserved in other species ([Table 4](#t0020){ref-type="table"}). Out of the remaining 13 alleles 10 affect residues that are also not conserved. Interestingly three mutations reside within the catalytic core of the enzyme. Since these strains are viable it is, however, unlikely that these lesions severely affect the function of the protein. Alternatively secondary mutations within these strains might be present that could compensate for any detrimental effect on enzyme function. Further studies would be required to ascertain if this is the case.

In our study we isolated and identified eight *mars-1* alleles all of which lead to a loss-of-function phenotype. Furthermore, the number of alleles isolated in *mars-1* is greater than the average number of alleles isolated for most genes in screens of this type ([@bb0060], [@bb0070], [@bb0065], [@bb0090], [@bb0075], [@bb0080], [@bb0085]). This indicates that *let-65* (*mars-1*) is a large mutagenic target for EMS. The availability of the loss of function alleles allows for further exploration of the gene\'s structure and function in a tractable model system. Moreover, it will facilitate a better understanding of ARS, which will lead to a deeper understanding of the complete protein synthesis machinery in all organisms including humans.

The following are the supplementary data related to this articleSupplementary Table 1List of sequencing primers.
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![Physical map of the *unc-22* region of LGIV including our aCGH deficiency mapping data.\
A. Schematic of LGIV showing the regions uncovered by the deficiencies analyzed in this study is shown at the top of the figure (dark gray). aCGH data for the region around the four analyzed deficiencies is also shown. Commonly used genetic markers and the physical positions of the deficiency breakpoints (estimated to within 0.5 kb) are shown above the array data. A schematic describing the seven zones defined by the breakpoints of the deficiencies is shown below the array data. *let-56* is in either zone five or zone six. B. An expansion of zone three showing the four candidate genes for *let-*65. The region covered by the fosmid used in complementation tests is depicted above the gene models. C. Schematic showing protein structures of human MetRS and *C. elegans* MARS-1. Conserved domains and their locations are indicated. The positions of identified *mars-1* mutations are shown. Figure not to scale.](gr1){#f0005}

![*C. elegans* MARS-1 alignment with its human (GenBank accession no. [NP_004981](ncbi-p:NP_004981){#ir0035}), *D. melanogaster* (GenBank accession no. [NP_611382](ncbi-p:NP_611382){#ir0040}), and *S. cerevisiae* (GenBank accession no. [CAA97293](ncbi-p:CAA97293){#ir0045}) orthologs showing conserved amino acids and identified *let-65* mutations. MARS-1 is evolutionarily well conserved with 58% identity and 71% similarity to its human ortholog. Red lines indicate the positions of amino acid changes in *let-65* alleles. *s1222* prevents the splicing of the first intron. *s1777* induces a stop codon that prematurely truncates the protein.](gr2){#f0010}

###### 

aCGH defined deficiency breakpoints and gene complement.

  Zone   Left breakpoint   Right breakpoint   Genes within zones   Size kb                                                                                              
  ------ ----------------- ------------------ -------------------- ------------ ------------------------------------------- ------------------------------------------- ----------
  1      10,942,926        10,947,094         11,070,201           11,076,154   Y69E1A.1                                    Y5F2A.3                                     123--134
  2      11,070,201        11,076,154         11,629,649           11,629,799   Y5F2A.4                                     lys-6                                       553--560
  3      11,629,649        11,629,799         11,639,511           11,639,570   F58B3.4                                     F58B3.7[a](#tf0010){ref-type="table-fn"}    10--11
  4      11,639,511        11,639,570         11,983,621           11,983,655   F58B3.7[a](#tf0010){ref-type="table-fn"}    *unc-22*[a](#tf0010){ref-type="table-fn"}   343--344
  5      11,983,621        11,983,655         12,243,159           12,251,414   *unc-22*[a](#tf0010){ref-type="table-fn"}   sre-16                                      252--253
  6      12,243,159        12,251,414         12,551,447           12,553,668   *sre-19*                                    ZK795.1[a](#tf0010){ref-type="table-fn"}    315--317
  7      12,551,447        12,553,668         12,757,572           12,776,111   ZK795.1[a](#tf0010){ref-type="table-fn"}    *inx-6*                                     196--204

Regions are annotated based on the probe sequence falling adjacent to the breakpoint position.

Breakpoints falling within a single gene.

###### 

Mutations identified in *let-65* by sequencing and BioEdit analysis.

  Allele    Nucleotide change   Codon mutation   Amino acid change
  --------- ------------------- ---------------- -------------------------------------
  *s174*    ND                  ND               ND[a](#tf0005){ref-type="table-fn"}
  *s254*    G1188A              gag → **a**ag    Glu-364 → Lys
  *s694*    G655A               gga → g**a**a    Gly-186 → Glu
  *s1083*   G429A               gga → g**a**a    Gly-126 → Glu
  *s1084*   G921A               gga → **a**ga    Gly-275 → Arg
  *s1154*   C1297T              ccc → c**t**c    Pro-400 → Leu
  *s1222*   G81A                (−) → **a**ga    (−)27 → Arg
  *s1730*   C174T               gct → g**t**t    Ala-41 → Val
  *s1777*   G1324A              tgg → t**a**g    Trp-409 → Stop

Not determined --- potentially a complex lesion.

###### 

Correlation of known viability phenotypes in ARS-family genes.

  Gene name   RNAi phenotype       Mutation phenotype \[allele\]
  ----------- -------------------- -----------------------------------
  *aars-1*    ste                  
  *aars-2*    emb; lvl; ste        
  *cars-1*    emb; let; lvl; ste   
  *cars-2*    ste                  
  *dars-1*    emb; lvl; ste        
  *dars-2*    emb; lvl; ste        let; ste \[*tm3799*\]
  *ears-1*    emb; lvl             
  *ears-2*    emb; lvl; ste        
  *fars-1*    emb; lvl; ste        
  *fars-2*    ND                   
  *fars-3*    emb; lvl; ste        
  *gars-1*    emb; lvl; ste        
  *hars-1*    emb; let; lvl; ste   let; ste \[*tm4074*\] ([@bb0210])
  *iars-1*    emb; ste             
  *iars-1*    emb; let             
  *kars-1*    emb; lvl; ste        
  *lars-1*    emb; let; lvl; ste   
  *lars-2*    emb                  let; ste \[*tm5774*\]
  *mars-1*    emb; lvl             
  *nars-1*    emb; let; lvl; ste   let; ste \[*tm524*\]
  *nars-2*    ND                   
  *pars-1*    emb; let; lvl; ste   
  *pars-2*    ND                   
  *qars-1*    emb; let; lvl; ste   
  *rars-1*    emb; lvl; ste        emb; lvl; ste \[*gc47*\]
  *rars-2*    emb; ste             
  *sars-1*    emb; lvl; ste        
  *sars-2*    emb                  
  *tars-1*    emb; let; lvl; ste   
  *vars-1*    emb; lvl; ste        
  *vars-2*    emb; let; lvl; ste   let; ste \[*tm3947*\]
  *wars-1*    emb; lvl; ste        
  *yars-1*    emb; lvl; ste        

emb = embryonic lethality, lvl = larval lethality, let = lethal, ste = sterile, ND = not determined.

Data source: WormBase,

http://www.wormbase.org

, release WS243, May 2014.

###### 

*mars-1* MMP mutations.

  Allele       Mutation   Effect             Domain affected      Type               Conserved residue
  ------------ ---------- ------------------ -------------------- ------------------ -------------------
  *gk213073*   C → T      A887T              None                 Missense           No
  *gk410589*   G → A      P865S              None                 Missense           No
  *gk445673*   C → T      Affects splicing   None                 Intron, splicing   No
  *gk485164*   C → T      A453T              Anticodon_1          Missense           No
  *gk509072*   C → T      D190N              tRNA-synt_1g         Missense           Yes
  *gk515000*   C → T      G668E              coiled_coil_region   Missense           No
  *gk541772*   G → A      P265L              tRNA-synt_1g         Missense           Yes
  *gk550543*   C → T      A613T              Anticodon_1          Missense           No
  *gk636296*   G → A      S837L              tRNA_bind            Missense           No
  *gk656240*   T → C      M844V              tRNA_bind            Missense           No
  *gk719138*   C → T      A431T              tRNA-synt_1g         Missense           Yes
  *gk780068*   C → T      D752N              None                 Missense           No
  *gk793812*   A → T      F412L              tRNA-synt_1g         Missense           No
  *gk889082*   G → A      A520V              Anticodon_1          Missense           No
